Background review for sodium laurilsulfate used as an excipient
23 July 2015
EMA/CHMP/351898/2014
Committee for Human Medicinal Products (CHMP)
In the context of the revision of the guideline on ‘Excipients in the label and package leaflet of medicinal products for human use’ (CPMP/463/00 Rev. 1)
Draft report published in support to the Q&A document.
EMA/CHMP/351898/2014
Committee for Human Medicinal Products (CHMP)
In the context of the revision of the guideline on ‘Excipients in the label and package leaflet of medicinal products for human use’ (CPMP/463/00 Rev. 1)
Draft report published in support to the Q&A document.